TB-500
Thymosin Beta-4 Fragment
TB-500 is the synthetic fragment of Thymosin Beta-4, a naturally occurring protein found in virtually all human and animal cells. Its systemic mechanism sets it apart — effective even when administered away from the site of injury, making it one of the most versatile tissue repair compounds in preclinical research.
At a Glance
TB-500's primary mechanism centers on actin regulation. By sequestering G-actin and upregulating Thymosin Beta-4 expression, it drives cell migration, proliferation, and tissue remodeling throughout the body — not just locally.
Unlike BPC-157, which tends toward localized cytoprotection, TB-500 operates more systemically. It can be administered away from an injury site and still reach the target tissue — a practical advantage that has shaped how researchers design multi-site injury studies.
The two compounds are frequently studied together because their mechanisms cover different biological territory and appear to produce additive outcomes in repair models.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
Actin Sequestration
Binds G-actin via the LKKTET motif, regulating actin polymerization dynamics and enabling accelerated cell migration into damaged tissue.
Angiogenesis
Promotes new vessel formation by upregulating VEGF and MMP pathways, supporting vascular repair and nutrient delivery to injury sites.
Anti-Inflammatory
Downregulates TNF-α, IL-6, and NF-κB signaling, reducing chronic inflammation in musculoskeletal and soft tissue models.
Tissue Remodeling
Activates fibroblasts and keratinocytes, accelerating collagen deposition and extracellular matrix reorganization in healing tissue.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Acceleration of muscle, tendon, and ligament repair in transection and crush models
- Wound healing via enhanced fibroblast and keratinocyte migration
- Cardiac tissue protection — studied in ischemic event models in rodents
- Reduction of scar tissue formation and improvement in remodeling quality
- CNS injury models — early preclinical findings for nerve repair
- Systemic administration studies — efficacy observed when injected distal to injury
- Fibrosis reduction in pulmonary and hepatic injury models
The systemic nature of TB-500's action makes it particularly valuable in research designs that can't rely on precise local injection — a practical advantage that has contributed to its popularity.
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026